Soneira and the Scramble for Ibogaine: Could the Iboga Plant Ever Be Integrated into Mainstream Western Healthcare?
Historical & modern Journalism moderate
AI-extracted · unverified · confirm at source
Investigates Soneira's $30M fundraise, Stanford patent controversy over ibogaine+magnesium for TBI, and tensions between indigenous IP, practitioner knowledge, and academic commercialisation.